Results 101 to 110 of about 20,679 (232)

Emergency Department Triage Nurses' Scope of Practice: An Observational Study

Journal of Clinical Nursing, Volume 35, Issue 9, Page 3942-3958, September 2026.
ABSTRACT Aim To explore emergency department triage nurses' scope of practice and activities related to their triage role and management of patients located in emergency department waiting areas. Design Exploratory, descriptive, observational study using naturalistic decision making.
Julie Considine, Elizabeth Oldland, Judy Currey, Philippa Blencowe, Katrina Maybury, Leanne Stella, Amy Pearson, Paul Buntine, Kate Curtis   +8 more
wiley   +1 more source

Life-threatening angioedema induced by angiotensin-converting enzyme inhibitor: two case reports

Zdravniški Vestnik, 2016
Background. Angioedema is a rare but potentially very serious complication of treatment with angiotensin converting enzyme inhibitors (ACEI). Angioedema is due to the accumulation of bradykinin, because angiotensin converting enzyme is the key enzyme for
Erik Rupnik, Stojan Kariž, Črtomir Iglič, Mihaela Zidarn   +3 more
doaj  

Preoperative Avapritinib for Localized PDGFRA‐Mutant GIST: Marked Pathologic Response, but Limited Feasibility at Standard Dosing

Cancer Medicine, Volume 15, Issue 8, August 2026.
In this two‐center retrospective series of eight patients with localized PDGFRA‐mutant gastric GIST treated with preoperative avapritinib, therapy produced substantial antitumor activity, including tumor reduction in 7 of 8 patients and complete or near‐complete pathologic response in all resected patients.
Tannaz Ranjbarian, Mark Antkowiak, Shirley Sarno, Shumei Kato, Adam M. Burgoyne, Skye C. Mayo, Michael C. Heinrich, Paul T. Fanta, Jason K. Sicklick   +8 more
wiley   +1 more source

Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Lanadelumab has been approved for hereditary angioedema (HAE) long‐term prophylaxis since 2018. The Phase 4, prospective ENABLE Study (NCT04130191) evaluated the long‐term effectiveness and safety of lanadelumab in clinical practice across Europe and the Middle East.
Andrea Zanichelli, Walter A. Wuillemin, Markus Magerl, Andreas Recke, Mauro Cancian, Emel Aygören‐Pürsün, Ramón Lleonart Bellfill, Aharon Kessel, Tamar Kinaciyan, Robin Lochbaum, Mona Al‐Ahmad, Irmgard Andresen, Maureen Watt, Natalie Khutoryansky, Daniel N. Castaner, Inmaculada Martinez‐Saguer   +15 more
wiley   +1 more source

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Berotralstat is a first‐line once‐daily oral prophylactic treatment for hereditary angioedema (HAE). Berolife was designed to evaluate the tolerability and effectiveness of berotralstat in real‐world conditions. Methods Berolife is an open‐label, multicenter, observational study conducted in France from September 2021 to January ...
Delphine Gobert, David Launay, Isabelle Boccon‐Gibod, Melisande Bourgoin‐Heck, Cyrille Hoarau, Yann Ollivier, Hervé Maillard, Fabien Pontille, Nicolas Ozanne, Magali Aubineau, Claire de Moreuil, Anne Gerber, Fabien Pelletier, Pierre‐Yves Jeandel, Aurélie Du‐Thanh, Marie‐Caroline Dalmas, Marie‐Caroline Taquet, Jean Schmidt, Amélie Servettaz, Amandine Perier, Enzo Cohen, Laure Carriat, Nicolas Lemaire, Mona Villedieu, Jean‐Charles Crave, Olivier Fain, Laurence Bouillet   +26 more
wiley   +1 more source

New Insights Into Immunomodulatory Strategies for Drug Hypersensitivity Reactions: An EAACI Task Force Report

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Drug hypersensitivity reactions (DHRs) are a global health concern and remain challenging to investigate owing to the heterogeneity of endotypes and phenotypes, as well as the lack of standardized biomarkers. Until recently, strict drug avoidance was the only management strategy for severe DHRs.
Ana Maria Copaescu, Valentina Gueli, Jitesh Chahuan, Waad Albalawi, Giovanna Sfriso, Mattia Giovannini, Leticia de las Vecillas, Aspasia Karavelia, Marina Labella, Ruben Fernandez‐Santamaria, Francesca Mori, Lene H. Garvey, Patrizia Bonadonna, Maria Jose Torres   +13 more
wiley   +1 more source

Ziziphus jujube Fruit Supplementation Improves Liver Enzymes, Lipid Profile, and Hepatic Steatosis but Not Fasting Blood Glucose in Patients With NAFLD: A Randomized Controlled Trial

Food Science &Nutrition, Volume 14, Issue 8, August 2026.
Daily supplementation with Ziziphus jujube fruit improved liver enzymes, lipid profile, and hepatic steatosis in patients with non‐alcoholic fatty liver disease (NAFLD), potentially through its antioxidant, anti‐inflammatory, and lipid‐modulating properties.
Ronak Borzooei, Karim Parastouei, Maryam Taghdir, Mojtaba Sepandi, Mohammad Ali Abyazi Heris   +4 more
wiley   +1 more source

The Burden of Urticaria in the Middle East and North Africa Region From 1990 to 2021: A Systematic Analysis Based on the GBD Study 2021

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Urticaria is a condition which can impair the quality of life of affected individuals. There is a lack of recent studies on the burden of this disease in the Middle East and North Africa (MENA) region. This article reported the incidence, prevalence, and disability‐adjusted life years (DALYs) of urticaria from 1990 to 2021 ...
Amir Sajad Bagheryan, Soroush Oraee, Mehra Fekri, Farzin Tahmasbi Arashlow, Hojjat Layegh, Seyed Aria Nejadghaderi, Shirin Zaresharifi   +6 more
wiley   +1 more source

Factors Influencing Self‐Reported Health in Puerto Rican Populations: A Systematic Review

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Puerto Ricans experience disproportionate chronic disease burden, structural barriers to care, and disparities in health outcomes. Self‐reported health is a validated indicator of morbidity, mortality, and healthcare utilization, yet its determinants in Puerto Rican populations remain insufficiently synthesized. This review
Anthony Vincent Razzano
wiley   +1 more source

Lack of Differences in the Pharmacokinetics of Therapeutic Monoclonal Antibodies Between Japanese and Non‐Japanese Individuals

The Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Evaluation of the pharmacokinetics (PK) of new drugs in Japanese individuals is regularly requested by the Japanese regulatory agency prior to participation in global clinical trials or for bridging approaches for regulatory approval. However, the need for PK assessments in the Japanese population may be less compelling for monoclonal ...
Paridhi Gupta, Ashish Sharma, Bernd Meibohm   +2 more
wiley   +1 more source